CN113262719A - Application of peptide-like compound, micro-nano metal powder and preparation method thereof - Google Patents
Application of peptide-like compound, micro-nano metal powder and preparation method thereof Download PDFInfo
- Publication number
- CN113262719A CN113262719A CN202110549512.3A CN202110549512A CN113262719A CN 113262719 A CN113262719 A CN 113262719A CN 202110549512 A CN202110549512 A CN 202110549512A CN 113262719 A CN113262719 A CN 113262719A
- Authority
- CN
- China
- Prior art keywords
- micro
- metal powder
- nano metal
- preparation
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 229910052751 metal Inorganic materials 0.000 title claims abstract description 78
- 239000002184 metal Substances 0.000 title claims abstract description 78
- 239000000843 powder Substances 0.000 title claims abstract description 64
- 150000001875 compounds Chemical class 0.000 title claims abstract description 50
- 238000002360 preparation method Methods 0.000 title claims abstract description 46
- 238000003756 stirring Methods 0.000 claims abstract description 28
- 108010043958 Peptoids Proteins 0.000 claims abstract description 22
- 238000006243 chemical reaction Methods 0.000 claims abstract description 15
- 150000003839 salts Chemical class 0.000 claims abstract description 15
- 239000003638 chemical reducing agent Substances 0.000 claims abstract description 14
- 239000002244 precipitate Substances 0.000 claims abstract description 13
- 239000002904 solvent Substances 0.000 claims abstract description 13
- 239000002270 dispersing agent Substances 0.000 claims abstract description 10
- 238000001914 filtration Methods 0.000 claims abstract description 6
- 238000002156 mixing Methods 0.000 claims abstract description 5
- -1 beta-hydroxybutyryl-amino Chemical group 0.000 claims description 30
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 23
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 22
- 238000000034 method Methods 0.000 claims description 21
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 14
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 12
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 11
- 239000011668 ascorbic acid Substances 0.000 claims description 11
- 235000010323 ascorbic acid Nutrition 0.000 claims description 11
- 229960005070 ascorbic acid Drugs 0.000 claims description 11
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical group [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims description 10
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims description 9
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 9
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 claims description 9
- 229910001868 water Inorganic materials 0.000 claims description 8
- 235000008206 alpha-amino acids Nutrition 0.000 claims description 6
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 claims description 6
- 150000001371 alpha-amino acids Chemical group 0.000 claims description 4
- 150000001879 copper Chemical class 0.000 claims description 4
- 238000012643 polycondensation polymerization Methods 0.000 claims description 4
- 229920001184 polypeptide Chemical group 0.000 claims description 4
- 108090000765 processed proteins & peptides Chemical group 0.000 claims description 4
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 4
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 claims description 3
- KWSLGOVYXMQPPX-UHFFFAOYSA-N 5-[3-(trifluoromethyl)phenyl]-2h-tetrazole Chemical compound FC(F)(F)C1=CC=CC(C2=NNN=N2)=C1 KWSLGOVYXMQPPX-UHFFFAOYSA-N 0.000 claims description 3
- GSNUFIFRDBKVIE-UHFFFAOYSA-N DMF Natural products CC1=CC=C(C)O1 GSNUFIFRDBKVIE-UHFFFAOYSA-N 0.000 claims description 3
- 229910000365 copper sulfate Inorganic materials 0.000 claims description 3
- ORTQZVOHEJQUHG-UHFFFAOYSA-L copper(II) chloride Chemical compound Cl[Cu]Cl ORTQZVOHEJQUHG-UHFFFAOYSA-L 0.000 claims description 3
- XTVVROIMIGLXTD-UHFFFAOYSA-N copper(II) nitrate Chemical compound [Cu+2].[O-][N+]([O-])=O.[O-][N+]([O-])=O XTVVROIMIGLXTD-UHFFFAOYSA-N 0.000 claims description 3
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 claims description 3
- 235000019253 formic acid Nutrition 0.000 claims description 3
- 235000006408 oxalic acid Nutrition 0.000 claims description 3
- 230000035484 reaction time Effects 0.000 claims description 3
- 239000012279 sodium borohydride Substances 0.000 claims description 3
- 229910000033 sodium borohydride Inorganic materials 0.000 claims description 3
- 229910001379 sodium hypophosphite Inorganic materials 0.000 claims description 3
- 239000004094 surface-active agent Substances 0.000 abstract description 7
- 238000005054 agglomeration Methods 0.000 abstract description 5
- 230000002776 aggregation Effects 0.000 abstract description 5
- 230000015572 biosynthetic process Effects 0.000 abstract description 3
- 238000003786 synthesis reaction Methods 0.000 abstract description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 27
- WHBMMWSBFZVSSR-UHFFFAOYSA-N 3-hydroxybutyric acid Chemical compound CC(O)CC(O)=O WHBMMWSBFZVSSR-UHFFFAOYSA-N 0.000 description 18
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 18
- 239000008367 deionised water Substances 0.000 description 16
- 229910021641 deionized water Inorganic materials 0.000 description 16
- 229940024606 amino acid Drugs 0.000 description 14
- CPKCDWXPIHGDSD-LXZQMHNESA-N OC(CC(=O)N[C@@H]([C@@H](C)CC)C(=O)O)C Chemical compound OC(CC(=O)N[C@@H]([C@@H](C)CC)C(=O)O)C CPKCDWXPIHGDSD-LXZQMHNESA-N 0.000 description 13
- 238000005406 washing Methods 0.000 description 12
- 108010016626 Dipeptides Proteins 0.000 description 11
- 239000002245 particle Substances 0.000 description 11
- 238000001035 drying Methods 0.000 description 9
- 230000002194 synthesizing effect Effects 0.000 description 9
- 238000012876 topography Methods 0.000 description 9
- 238000005160 1H NMR spectroscopy Methods 0.000 description 8
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 8
- 235000011114 ammonium hydroxide Nutrition 0.000 description 8
- 229910000366 copper(II) sulfate Inorganic materials 0.000 description 8
- 239000000243 solution Substances 0.000 description 8
- 238000001308 synthesis method Methods 0.000 description 6
- 238000002441 X-ray diffraction Methods 0.000 description 5
- 150000001370 alpha-amino acid derivatives Chemical group 0.000 description 5
- NMYQKDXBZKTRLS-AGROOBSYSA-N (2S)-2-[[(2S)-2-[[2-(3-hydroxybutanoylamino)acetyl]amino]propanoyl]amino]-4-methylsulfanylbutanoic acid Chemical compound OC(CC(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCSC)C(=O)O)C NMYQKDXBZKTRLS-AGROOBSYSA-N 0.000 description 4
- LQXLODGQLFQLAW-GDVGLLTNSA-N (2s)-2-(3-hydroxybutanoylamino)pentanedioic acid Chemical compound CC(O)CC(=O)N[C@H](C(O)=O)CCC(O)=O LQXLODGQLFQLAW-GDVGLLTNSA-N 0.000 description 4
- FELSNFUBVBSUPL-UZPQQBEXSA-N CC(C)C[C@@H](C(N[C@@H](C(C)C)C(N[C@@H](CCC(O)=O)C(O)=O)=O)=O)NC(CC(C)O)=O Chemical compound CC(C)C[C@@H](C(N[C@@H](C(C)C)C(N[C@@H](CCC(O)=O)C(O)=O)=O)=O)NC(CC(C)O)=O FELSNFUBVBSUPL-UZPQQBEXSA-N 0.000 description 4
- ZSLDJTNGNZRMSQ-RBNADJMDSA-N CC[C@H](C)[C@@H](C(NCC(O)=O)=O)NC([C@H](C(C)C)NC([C@H](C)NC(CC(C)O)=O)=O)=O Chemical compound CC[C@H](C)[C@@H](C(NCC(O)=O)=O)NC([C@H](C(C)C)NC([C@H](C)NC(CC(C)O)=O)=O)=O ZSLDJTNGNZRMSQ-RBNADJMDSA-N 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- BQFLYHMTMWHCMF-VWMHFEHESA-N N[C@@H](CCSC)C(=O)O.OC(CC(=O)NCC(=O)O)C Chemical compound N[C@@H](CCSC)C(=O)O.OC(CC(=O)NCC(=O)O)C BQFLYHMTMWHCMF-VWMHFEHESA-N 0.000 description 4
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 4
- JCXLZWMDXJFOOI-WCCKRBBISA-N ethyl (2s)-2-aminopropanoate;hydrochloride Chemical compound Cl.CCOC(=O)[C@H](C)N JCXLZWMDXJFOOI-WCCKRBBISA-N 0.000 description 4
- 239000000706 filtrate Substances 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- TXTWXQXDMWILOF-UHFFFAOYSA-N (2-ethoxy-2-oxoethyl)azanium;chloride Chemical compound [Cl-].CCOC(=O)C[NH3+] TXTWXQXDMWILOF-UHFFFAOYSA-N 0.000 description 3
- ANKPSSPTFFQSKS-CBAPKCEASA-N (2s,3s)-2-(butanoylamino)-3-methylpentanoic acid Chemical compound CCCC(=O)N[C@H](C(O)=O)[C@@H](C)CC ANKPSSPTFFQSKS-CBAPKCEASA-N 0.000 description 3
- SYQNQPHXKWWZFS-YFKPBYRVSA-N (4s)-4-amino-5-ethoxy-5-oxopentanoic acid Chemical compound CCOC(=O)[C@@H](N)CCC(O)=O SYQNQPHXKWWZFS-YFKPBYRVSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 238000009826 distribution Methods 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000012071 phase Substances 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- FGTJJHCZWOVVNH-UHFFFAOYSA-N tert-butyl-[tert-butyl(dimethyl)silyl]oxy-dimethylsilane Chemical compound CC(C)(C)[Si](C)(C)O[Si](C)(C)C(C)(C)C FGTJJHCZWOVVNH-UHFFFAOYSA-N 0.000 description 3
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 2
- LZZYPRNAOMGNLH-UHFFFAOYSA-M Cetrimonium bromide Chemical compound [Br-].CCCCCCCCCCCCCCCC[N+](C)(C)C LZZYPRNAOMGNLH-UHFFFAOYSA-M 0.000 description 2
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 229910052802 copper Inorganic materials 0.000 description 2
- 239000010949 copper Substances 0.000 description 2
- PQGVTLQEKCJXKF-RGMNGODLSA-N ethyl (2s)-2-amino-3-methylbutanoate;hydron;chloride Chemical compound Cl.CCOC(=O)[C@@H](N)C(C)C PQGVTLQEKCJXKF-RGMNGODLSA-N 0.000 description 2
- KPWCQEUBJAIORR-RGMNGODLSA-N ethyl (2s)-2-amino-4-methylsulfanylbutanoate;hydrochloride Chemical compound Cl.CCOC(=O)[C@@H](N)CCSC KPWCQEUBJAIORR-RGMNGODLSA-N 0.000 description 2
- QQGRWNMNWONMOO-LEUCUCNGSA-N ethyl (2s,3s)-2-amino-3-methylpentanoate;hydron;chloride Chemical compound Cl.CCOC(=O)[C@@H](N)[C@@H](C)CC QQGRWNMNWONMOO-LEUCUCNGSA-N 0.000 description 2
- 239000004220 glutamic acid Substances 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 238000000053 physical method Methods 0.000 description 2
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 159000000000 sodium salts Chemical class 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- FPGGTKZVZWFYPV-UHFFFAOYSA-M tetrabutylammonium fluoride Chemical compound [F-].CCCC[N+](CCCC)(CCCC)CCCC FPGGTKZVZWFYPV-UHFFFAOYSA-M 0.000 description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 2
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical class [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- NOUDPBCEONUCOV-FJXQXJEOSA-N [(2s)-1-ethoxy-4-methyl-1-oxopentan-2-yl]azanium;chloride Chemical compound Cl.CCOC(=O)[C@@H](N)CC(C)C NOUDPBCEONUCOV-FJXQXJEOSA-N 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- AZDRQVAHHNSJOQ-UHFFFAOYSA-N alumane Chemical class [AlH3] AZDRQVAHHNSJOQ-UHFFFAOYSA-N 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 235000009697 arginine Nutrition 0.000 description 1
- 235000009582 asparagine Nutrition 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 125000000198 beta-muramyl group Chemical group N[C@H]1[C@H](O)O[C@@H]([C@H]([C@@H]1O[C@@H](C(=O)*)C)O)CO 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 150000001868 cobalt Chemical class 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- DZGCGKFAPXFTNM-UHFFFAOYSA-N ethanol;hydron;chloride Chemical compound Cl.CCO DZGCGKFAPXFTNM-UHFFFAOYSA-N 0.000 description 1
- DUJGQVVONTYHLT-RGMNGODLSA-N ethyl (2s)-pyrrolidine-2-carboxylate;hydrochloride Chemical compound Cl.CCOC(=O)[C@@H]1CCCN1 DUJGQVVONTYHLT-RGMNGODLSA-N 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 235000004554 glutamine Nutrition 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 235000014304 histidine Nutrition 0.000 description 1
- 150000002505 iron Chemical class 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- 235000014705 isoleucine Nutrition 0.000 description 1
- 238000011031 large-scale manufacturing process Methods 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 238000004377 microelectronic Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 150000002751 molybdenum Chemical class 0.000 description 1
- 239000002086 nanomaterial Substances 0.000 description 1
- 150000002815 nickel Chemical class 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 238000001144 powder X-ray diffraction data Methods 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 238000006722 reduction reaction Methods 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000000967 suction filtration Methods 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 150000003751 zinc Chemical class 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K23/00—Use of substances as emulsifying, wetting, dispersing, or foam-producing agents
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B22—CASTING; POWDER METALLURGY
- B22F—WORKING METALLIC POWDER; MANUFACTURE OF ARTICLES FROM METALLIC POWDER; MAKING METALLIC POWDER; APPARATUS OR DEVICES SPECIALLY ADAPTED FOR METALLIC POWDER
- B22F1/00—Metallic powder; Treatment of metallic powder, e.g. to facilitate working or to improve properties
- B22F1/05—Metallic powder characterised by the size or surface area of the particles
- B22F1/054—Nanosized particles
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B22—CASTING; POWDER METALLURGY
- B22F—WORKING METALLIC POWDER; MANUFACTURE OF ARTICLES FROM METALLIC POWDER; MAKING METALLIC POWDER; APPARATUS OR DEVICES SPECIALLY ADAPTED FOR METALLIC POWDER
- B22F9/00—Making metallic powder or suspensions thereof
- B22F9/16—Making metallic powder or suspensions thereof using chemical processes
- B22F9/18—Making metallic powder or suspensions thereof using chemical processes with reduction of metal compounds
- B22F9/24—Making metallic powder or suspensions thereof using chemical processes with reduction of metal compounds starting from liquid metal compounds, e.g. solutions
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y30/00—Nanotechnology for materials or surface science, e.g. nanocomposites
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y40/00—Manufacture or treatment of nanostructures
Landscapes
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nanotechnology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Physics & Mathematics (AREA)
- Condensed Matter Physics & Semiconductors (AREA)
- General Physics & Mathematics (AREA)
- Materials Engineering (AREA)
- Inorganic Chemistry (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Composite Materials (AREA)
- Manufacturing & Machinery (AREA)
- Manufacture Of Metal Powder And Suspensions Thereof (AREA)
- Powder Metallurgy (AREA)
Abstract
The invention provides application of a peptide-like compound, micro-nano metal powder and a preparation method thereof, wherein the peptide-like compound is used as a dispersing agent in preparation of the micro-nano metal powder; the preparation method of the micro-nano metal powder comprises the following steps: adding a peptoid compound and a metal salt into a solvent, uniformly mixing, adding a reducing agent, stirring for reaction, filtering, and collecting precipitates to obtain the micro-nano metal powder. The peptoid compound is used as a dispersing agent in the preparation of the micro-nano metal powder, so that the agglomeration of the micro-nano metal powder can be inhibited, the prepared micro-nano metal powder is uniformly dispersed, and compared with the conventional preparation process of the micro-nano metal powder, the preparation process of the peptoid compound is more environment-friendly by using a surfactant; the preparation route is simple, the synthesis condition is mild, and the operability is strong.
Description
Technical Field
The invention relates to the technical field of nano materials, in particular to application of a peptide-like compound, micro-nano metal powder and a preparation method thereof.
Background
Micro-nano metal powder, especially micro-nano copper powder, has excellent conductivity, so that the micro-nano copper powder is widely applied to the fields of catalysis, electronic paste, microelectronics, solid lubricants and the like. At present, the preparation method of micro-nano metal powder is divided into a physical method and a chemical method, and the physical method has great dependence on equipment and high production cost, so that the preparation method is greatly restricted. At present, a chemical reduction method is usually adopted to prepare micro-nano metal powder, the method is simple and convenient to operate and low in production cost, but in order to prevent phenomena such as oxidation and agglomeration of nano copper in a synthesis process, surfactants such as polyvinylpyrrolidone (PVP), Cetyl Trimethyl Ammonium Bromide (CTAB) and the like are usually required to be added in the production process, and although the surfactants can achieve good dispersion effects, the surfactants have toxicity and can damage the environment particularly in large-scale production, so that further use of the surfactants is greatly limited. Therefore, a technical scheme that the traditional surfactant is not used and the prepared micro-nano metal powder is uniformly dispersed is needed.
Disclosure of Invention
In view of the above, the invention provides an application of a peptide-like compound, micro-nano metal powder and a preparation method thereof, so as to solve or partially solve the technical problems in the prior art.
In a first aspect, the invention provides an application of a peptoid compound, and an application of the peptoid compound as a dispersant in preparation of micro-nano metal powder, wherein the peptoid compound is a beta-hydroxybutyryl-amino acid compound, and a structural formula of the beta-hydroxybutyryl-amino acid is as follows:
(R)nis alpha-amino acid substituent or polypeptide chain formed by alpha-amino acid condensation polymerization.
In a second aspect, the invention also provides a preparation method of the micro-nano metal powder, which comprises the following steps:
and adding the peptoid compound and the metal salt into a solvent, uniformly mixing, adding a reducing agent, stirring for reaction, filtering, and collecting precipitates to obtain the micro-nano metal powder.
Preferably, in the preparation method of the micro-nano metal powder, the metal salt is copper salt.
Preferably, in the preparation method of the micro-nano metal powder, the copper salt comprises at least one of copper sulfate, copper chloride and copper nitrate.
Preferably, in the preparation method of the micro-nano metal powder, the reducing agent comprises at least one of ascorbic acid, formic acid, oxalic acid, sodium borohydride and sodium hypophosphite.
Preferably, in the method for preparing the micro-nano metal powder, the solvent includes at least one of water, DMF, DMSO, ethylene glycol, glycerol, and acetone.
Preferably, the preparation method of the micro-nano metal powder comprises the steps of adding the peptoid compound and the metal salt into a solvent, uniformly mixing, adding a reducing agent, adjusting the pH value to 7-10, stirring for reaction, filtering, and collecting precipitates to obtain the micro-nano metal powder.
Preferably, in the preparation method of the micro-nano metal powder, the reaction time is 0.5-1 h in the step of stirring reaction.
Preferably, in the preparation method of the micro-nano metal powder, the mass-volume ratio of the peptoid compound, the metal salt, the reducing agent and the solvent is (0.5-5) g, (0.5-10) g, (1-5) g and (50-500) mL.
In a third aspect, the invention also provides micro-nano metal powder prepared by the preparation method.
Compared with the prior art, the application of the peptide-like compound, the micro-nano metal powder and the preparation method thereof have the following beneficial effects:
(1) the peptoid compound is used as a dispersing agent in the preparation of the micro-nano metal powder, so that the agglomeration of the micro-nano metal powder can be inhibited, the prepared micro-nano metal powder is uniformly dispersed, and compared with the conventional preparation process of the micro-nano metal powder, the preparation process of the peptoid compound is more environment-friendly by using a surfactant;
(2) according to the preparation method of the micro-nano metal powder, the peptoid compound is used as the dispersing agent, and the uniformly dispersed micro-nano metal powder can be prepared;
(3) according to the preparation method of the micro-nano metal powder, the peptide-like compounds with different structural formulas can be used for preparing the micro-nano metal powder with different shapes, particle size distributions and structures, so that the structure and the shape of the micro-nano metal powder can be regulated.
Drawings
In order to more clearly illustrate the embodiments of the present invention or the technical solutions in the prior art, the drawings used in the description of the embodiments or the prior art will be briefly described below. It is obvious that the drawings in the following description are only some embodiments of the invention, and that for a person skilled in the art, other drawings can be derived from them without inventive effort.
FIG. 1 is a surface topography of micro-nano copper powder prepared in embodiment 1 of the invention;
FIG. 2 is a surface topography of the micro-nano copper powder prepared in embodiment 2 of the invention;
FIG. 3 is a surface topography of the micro-nano copper powder prepared in embodiment 3 of the invention;
FIG. 4 is a surface topography of the micro-nano copper powder prepared in embodiment 4 of the invention;
FIG. 5 is a surface topography of the micro-nano copper powder prepared in example 5 of the present invention;
FIG. 6 is a surface topography of the micro-nano copper powder prepared in example 6 of the present invention;
FIG. 7 is a surface topography of the micro-nano copper powder prepared in example 7 of the present invention;
FIG. 8 is a surface topography of the micro-nano copper powder prepared in example 8 of the present invention;
FIG. 9 is an XRD (X-ray diffraction) spectrum of the micro-nano copper powder prepared in the embodiment 1 of the invention;
FIG. 10 is a graph showing the variation of the resistivity of the micro-nano copper powder prepared in the embodiment 1 of the present invention with pressure;
fig. 11 is a graph showing the variation of the electrical conductivity of the micro-nano copper powder prepared in embodiment 1 of the present invention with pressure.
Detailed Description
In the following, the technical solutions in the embodiments of the present invention will be clearly and completely described in conjunction with the embodiments of the present invention, and it is obvious that the described embodiments are only a part of the embodiments of the present invention, and not all of the embodiments. All other embodiments, which can be obtained by a person skilled in the art without any inventive step based on the embodiments of the present invention, are within the scope of the present invention.
The embodiment of the application provides application of a peptide-like compound, in particular to application of the peptide-like compound as a dispersing agent in preparation of micro-nano metal powder, wherein the peptide-like compound is a beta-hydroxybutyryl-amino acid compound, and the structural formula of the beta-hydroxybutyryl-amino acid is as follows:
(R)nis alpha-amino acid substituent or polypeptide chain formed by alpha-amino acid condensation polymerization.
It should be noted that, in the embodiment of the present application, the peptoid compound is used as a dispersant in the preparation of the micro-nano metal powder, so that the agglomeration of the micro-nano metal powder can be inhibited, and the micro-nano metal powder is uniformly dispersed. In particular, the peptoid compound in the embodiment of the application is a beta-hydroxybutyryl-amino acid compound, the specific structure and the synthesis method thereof adopt the prior art, and the application does not improve the structure and the synthesis method.
Specifically, in some embodiments, the α -amino acid can be alanine, arginine, aspartic acid, cysteine, glutamine, glutamic acid, histidine, isoleucine, glycine, asparagine, leucine, lysine, methionine, phenylalanine, proline, serine, threonine, tryptophan, tyrosine, valine, or the like, and the corresponding (R) n is a polypeptide chain formed by condensation polymerization of the above α -amino acids.
In some embodiments, the β -hydroxybutyryl-amino acid compound includes dipeptide, tripeptide, tetrapeptide, pentapeptide, and like peptoid compounds formed from β -hydroxybutyric acid and various α -amino acids.
In some embodiments, the beta-hydroxybutyryl-amino acid compound is a beta-hydroxybutyryl-isoleucine pseudo-dipeptide having the formula
In some embodiments, the beta-hydroxybutyryl-amino acid compound is a beta-hydroxybutyryl-glutamic acid pseudodipeptide having the formula
In some embodiments, the beta-hydroxybutyryl-amino acid compound is a pseudo-tripeptide of beta-hydroxybutyryl-alanine-glutamic acid having the formula
In some embodiments, the beta-hydroxybutyryl-amino acid compound is a beta-hydroxybutyryl-glycine-methionine pseudo-tripeptide of formula
In some embodiments, the beta-hydroxybutyryl-amino acid compound is a beta-hydroxybutyryl-alanine-proline pseudo-tripeptide of formula
In some embodiments, the β -hydroxybutyryl-amino acid compound is a β -hydroxybutyryl-leucyl-valyl-glutamic acid pseudotetrapeptide having the structural formula
In some embodiments, the β -hydroxybutyryl-amino acid compound is a β -hydroxybutyryl-glycyl-alanyl-methionine pseudotetrapeptide having the formula
In some embodiments, the β -hydroxybutyryl-amino acid compound is a β -hydroxybutyryl-alanyl-valyl-isoleucyl-glycine pseudopentapeptide having the structural formula
Based on the same invention concept, the invention also provides a preparation method of the micro-nano metal powder, which comprises the following steps:
and adding the peptoid compound and the metal salt into a solvent, uniformly mixing, adding a reducing agent, stirring for reaction, filtering, and collecting precipitates to obtain the micro-nano metal powder.
In this embodiment, specific micro-nano metal powder includes cobalt powder, nickel powder, zinc powder, aluminum powder, copper powder, iron powder, molybdenum powder, and the like, corresponding metal salts are cobalt salt, nickel salt, zinc salt, aluminum salt, copper salt, iron salt, molybdenum salt, and the like, and specific metal salts are sulfate, nitrate, chloride, and the like of corresponding metals. The peptoid compounds with different structural formulas can be used for preparing micro-nano metal powder with different shapes, particle size distributions and structures, so that the structure and the shape of the micro-nano metal powder can be regulated.
In some embodiments, the metal salt is a copper salt.
In some embodiments, the copper salt comprises at least one of copper sulfate, copper chloride, and copper nitrate.
In some embodiments, the reducing agent comprises at least one of ascorbic acid, formic acid, oxalic acid, sodium borohydride, and sodium hypophosphite.
In some embodiments, the solvent comprises at least one of water, DMF, DMSO, ethylene glycol, glycerol, and acetone. Wherein, DMF is N, N-dimethylformamide, and DMSO is dimethyl sulfoxide.
In some embodiments, the peptoid compound and the metal salt are added into a solvent, uniformly mixed, added with a reducing agent, adjusted to have a pH value of 7-10, stirred for reaction, filtered, and collected for precipitation, so as to obtain the micro-nano metal powder.
In some embodiments, the reaction time in the stirring step is 0.5 to 1 hour.
In some embodiments, the mass-to-volume ratio of the peptoid compound, the metal salt, the reducing agent and the solvent is (0.5-5) g, (0.5-10) g, (1-5) g and (50-500) mL.
Based on the same inventive concept, the embodiment of the application also provides the micro-nano metal powder prepared by the preparation method.
The following further describes a preparation method of the micro-nano metal powder according to the present application with specific examples.
Example 1
The embodiment of the application provides a preparation method of micro-nano copper powder, which comprises the following steps:
0.01mol of CuSO4Dissolving 5g of beta-hydroxybutyryl-isoleucine pseudo dipeptide in 0.5L of deionized water, stirring uniformly, adding 0.02mol of ascorbic acid, adding ammonia water to adjust the pH value to 7, stirring to react for 3h, centrifuging to collect precipitate, cleaning with deionized water and ethanol, and drying at 40 ℃ to obtain the micro-nano copper powder.
The synthesis method of the beta-hydroxybutyryl-isoleucine pseudo dipeptide comprises the following steps:
s1, adding 0.02mol of tert-butyl dimethyl silyl ether beta-hydroxybutyric acid, 0.02mol of isoleucine ethyl ester hydrochloride and 0.002mol of 4-dimethylamino pyridine into 100mL of dichloromethane, then adding 0.024mol of triethylamine, and stirring to react for 30 minutes to obtain a reaction solution;
s2, dissolving 0.03mol of N, N' -dicyclohexylcarbodiimide in 40mL of dichloromethane, then dripping the reaction solution into the dichloromethane, stirring and reacting for 3 hours at room temperature after dripping, then carrying out suction filtration, washing the filtrate twice with 80mL of water, washing the filtrate twice with 30mL of 0.1M dilute hydrochloric acid, washing the filtrate once with 30mL of saturated sodium bicarbonate aqueous solution, washing the filtrate once with 30mL of saturated sodium chloride aqueous solution, drying the dichloromethane phase and concentrating;
s3, dissolving the condensed concentrated solution with 90mL of tetrahydrofuran, adding 1 equivalent of tetrabutyl ammonium fluoride, stirring at room temperature for 2h, then adding water to quench the reaction, removing the tetrahydrofuran under reduced pressure, extracting the water phase with 50mL of dichloromethane for 3 times respectively, combining the organic phases, washing with 50mL of saturated sodium chloride once, and concentrating; adding 1-time equivalent of 1M sodium hydroxide aqueous solution into the concentrated solution, keeping the pH value at 7-8, stirring for reacting for 1h, washing the reaction solution with 40mL dichloromethane for three times, concentrating the water phase, and recrystallizing with ethanol/acetone to obtain a white solid, namely the beta-hydroxybutyryl-isoleucine pseudo-dipeptide sodium salt; adding an equivalent hydrogen chloride ethanol solution into the beta-hydroxybutyryl-isoleucine pseudo dipeptide sodium salt, filtering and concentrating to obtain the beta-hydroxybutyryl-isoleucine pseudo dipeptide.
The nuclear magnetic data of the beta-hydroxybutyryl-isoleucine pseudo dipeptide prepared in the above way are as follows:1H NMR(400MHz,D2O)δ4.11(m,1H),4.02(m,1H),2.34(m,2H),1.75(m,1H),1.32(m,1H),1.12(d,3H),1.05(m,1H),0.80(m,6H).HRMS(ESI+):Calculated for C10H20NO4[M+H]+:218.1387;Found:218.1395。
example 2
The embodiment of the application provides a preparation method of micro-nano copper powder, which comprises the following steps:
0.01mol of CuSO45g of beta-hydroxybutyl acidDissolving acyl-glutamic acid pseudo dipeptide in 0.5L of deionized water, stirring uniformly, then adding 0.02mol of ascorbic acid, adding ammonia water to adjust the pH value to 7, stirring for reaction for 3 hours, centrifuging, collecting precipitate, washing with deionized water and ethanol, and finally drying at 40 ℃ to obtain the micro-nano copper powder.
The method for synthesizing the beta-hydroxybutyryl-glutamic acid pseudodipeptide can be referred to the method for synthesizing the beta-hydroxybutyryl-isoleucine pseudodipeptide in example 1, and specifically, the beta-hydroxybutyryl-glutamic acid pseudodipeptide is prepared from tert-butyldimethylsiloxane beta-hydroxybutyric acid and glutamic acid ethyl ester hydrochloride. The nuclear magnetic data of the beta-hydroxybutyryl-glutamic acid pseudo dipeptide is as follows:1HNMR(400MHz,D2O)δ4.23(m,1H),4.15(m,1H),2.49(m,2H),2.25(m,2H),2.09(m,1H),1.92(m,1H),1.26(d,3H).HRMS(ESI+):Calculated for C9H16NO6[M+H]+:234.0972;Found:234.0979。
example 3
The embodiment of the application provides a preparation method of micro-nano copper powder, which comprises the following steps:
0.01mol of CuSO4Dissolving 5g of beta-hydroxybutyryl-alanine-glutamic acid pseudo-tripeptide in 0.5L of deionized water, stirring uniformly, adding 0.02mol of ascorbic acid, adding ammonia water to adjust the pH value to 7, stirring for reaction for 3 hours, centrifuging to collect precipitate, washing with deionized water and ethanol, and finally drying at 40 ℃ to obtain the micro-nano copper powder.
Wherein, the synthesis method of the beta-hydroxybutyryl-alanine-glutamic acid pseudo tripeptide can refer to the beta-hydroxy in the example 1
The synthesis process of butyryl-isoleucine pseudo dipeptide includes the specific steps of preparing tert-butyl dimethyl silyl ether beta-hydroxy butyric acid, alanine ethyl ester hydrochloride and glutamic acid ethyl ester hydrochloride. Nuclear magnetic data for the β -hydroxybutyryl-alanine-glutamic acid pseudo-tripeptide are:1H NMR(400MHz,D2O)δ4.25(m,1H),4.09(m,1H),4.00(m,1H),2.33(m,2H),2.07(m,2H),1.95(m,1H),1.78(m,1H),1.28(m,3H),1.11(d,3H).HRMS(ESI+):Calculated for C12H21N2O7[M+H]+:305.1343;Found:305.1349。
example 4
The embodiment of the application provides a preparation method of micro-nano copper powder, which comprises the following steps:
0.01mol of CuSO4Dissolving 5g of beta-hydroxybutyryl-glycine-methionine pseudo-tripeptide in 0.5L of deionized water, stirring uniformly, adding 0.02mol of ascorbic acid, adding ammonia water to adjust the pH value to 7, stirring for reacting for 3 hours, centrifuging to collect precipitate, washing with deionized water and ethanol, and finally drying at 40 ℃ to obtain the micro-nano copper powder.
Wherein, the synthesis method of the beta-hydroxybutyryl-glycine-methionine pseudo tripeptide can be referred to the beta-hydroxy group in example 1
The butyryl-isoleucine pseudo dipeptide is prepared with tert-butyl dimethyl silyl ether beta-hydroxy butyric acid, glycine ethyl ester hydrochloride and methionine ethyl ester hydrochloride. The nuclear magnetic data of the beta-hydroxybutyryl-glycine-methionine pseudo-tripeptide are as follows:1H NMR(400MHz,D2O)δ4.21(m,1H),4.07(m,1H),3.84(m,2H),2.35(m,4H),2.00(m,1H),1.98(s,3H),1.80(m,1H),1.13(d,3H).HRMS(ESI+):Calculated for C11H21N2O5S[M+H]+:293.1166;Found:293.1173。
example 5
The embodiment of the application provides a preparation method of micro-nano copper powder, which comprises the following steps:
0.01mol of CuSO4Dissolving 5g of beta-hydroxybutyryl-alanine-proline pseudo-tripeptide in 0.5L of deionized water, stirring uniformly, adding 0.02mol of ascorbic acid, adding ammonia water to adjust the pH value to 7, stirring for reacting for 3 hours, centrifuging to collect precipitate, washing with deionized water and ethanol, and finally drying at 40 ℃ to obtain the micro-nano copper powder.
Wherein, the synthesis method of the pseudo tripeptide of beta-hydroxybutyryl-alanine-proline can refer to the beta-hydroxy-in example 1
A process for synthesizing butyryl-isoleucine pseudo dipeptide from tert-butyldimethylsiloxane beta-hydroxyButyric acid and alanine ethyl ester hydrochloride, proline ethyl ester hydrochloride. The nuclear magnetic data of the beta-hydroxybutyryl-alanine-proline pseudo tripeptide are as follows:1H NMR(400MHz,D2O)δ4.60(m,1H),4.16(m,2H),3.55(m,2H),2.31(m,2H),2.01(m,2H),1.84(m,2H),1.28(m,3H),1.12(m,3H).HRMS(ESI+):Calculated for C12H21N2O5[M+H]+:273.1445;Found:273.1454。
example 6
The embodiment of the application provides a preparation method of micro-nano copper powder, which comprises the following steps:
0.01mol of CuSO4Dissolving 5g of beta-hydroxybutyryl-leucyl-valyl-glutamic acid pseudo-tetrapeptide in 0.5L of deionized water, stirring uniformly, adding 0.02mol of ascorbic acid, adding ammonia water to adjust the pH value to 7, stirring to react for 3 hours, centrifuging to collect precipitates, washing with deionized water and ethanol, and finally drying at 40 ℃ to obtain the micro-nano copper powder.
The method for synthesizing the β -hydroxybutyryl-leucyl-valyl-glutamic acid pseudotetrapeptide can be referred to the method for synthesizing the β -hydroxybutyryl-isoleucine pseudodipeptide in example 1, and specifically, the β -hydroxybutyryl-isoleucine pseudodipeptide is prepared from tert-butyldimethylsiloxane β -hydroxybutyric acid, and leucine ethyl ester hydrochloride, valine ethyl ester hydrochloride, and glutamic acid ethyl ester hydrochloride. The nuclear magnetic data for the β -hydroxybutyryl-leucyl-valyl-glutamic acid pseudotetrapeptide is:1H NMR(400MHz,D2O)δ4.25(m,2H),4.06(m,1H),3.94(m,1H),2.51(m,2H),2.35(m,2H),2.11(m,2H),1.98(m,1H),1.52(m,3H),1.11(d,3H),0.76(m,12H).HRMS(ESI+):Calculated for C20H36N3O8[M+H]+:446.2497;Found:446.2504。
example 7
The embodiment of the application provides a preparation method of micro-nano copper powder, which comprises the following steps:
0.01mol of CuSO45g of beta-hydroxybutyryl-glycyl-alanyl-methionine pseudotetrapeptide in 0.5L of deionized water with stirringAnd uniformly stirring, adding 0.02mol of ascorbic acid, adding ammonia water to adjust the pH value to 7, stirring to react for 3 hours, centrifuging to collect precipitates, washing with deionized water and ethanol, and finally drying at 40 ℃ to obtain the micro-nano copper powder.
The method for synthesizing the β -hydroxybutyryl-glycyl-alanyl-methionine pseudotetrapeptide can be referred to the method for synthesizing the β -hydroxybutyryl-isoleucine pseudodipeptide in example 1, and specifically, the β -hydroxybutyryl-isoleucine pseudodipeptide is prepared from tert-butyldimethylsiloxane β -hydroxybutyric acid, glycine ethyl ester hydrochloride, alanine ethyl ester hydrochloride, and methionine ethyl ester hydrochloride. The nuclear magnetic data for the β -hydroxybutyryl-glycyl-alanyl-methionine pseudotetrapeptide are:1H NMR(400MHz,D2O)δ4.31(m,1H),4.22(m,1H),4.12(m,1H),3.84(m,2H),2.57(m,2H),2.37(m,2H),2.05(s,3H),1.95(m,2H),1.32(d,3H),1.12(d,3H).HRMS(ESI+):Calculated for C14H26N3O6S[M+H]+:364.1537;Found:364.1531。
example 8
The embodiment of the application provides a preparation method of micro-nano copper powder, which comprises the following steps:
0.01mol of CuSO4Dissolving 5g of beta-hydroxybutyryl-alanyl-valyl-isoleucyl-glycine pseudo-pentapeptide in 0.5L of deionized water, uniformly stirring, adding 0.02mol of ascorbic acid, adding ammonia water to adjust the pH value to 7, stirring to react for 3 hours, centrifugally collecting precipitates, cleaning with deionized water and ethanol, and finally drying at 40 ℃ to obtain the micro-nano copper powder.
The method for synthesizing β -hydroxybutyryl-alanyl-valyl-isoleucyl-glycine pseudopentapeptide can be referred to the method for synthesizing β -hydroxybutyryl-isoleucine pseudodipeptide in example 1, and specifically, it is prepared from tert-butyldimethylsiloxane β -hydroxybutyric acid and alanine ethyl ester hydrochloride, valine ethyl ester hydrochloride, isoleucine ethyl ester hydrochloride, glycine ethyl ester hydrochloride. The nuclear magnetic data for the β -hydroxybutyryl-alanyl-valyl-isoleucyl-glycine pseudo-pentapeptide is:1H NMR(400MHz,D2O)δ4.21(m,2H),4.05(m,4H),2.35(m,2H),2.00(m,1H),1.83(m,1H),1.35(m,4H),1.09(m,4H),0.77(m,12H).HRMS(ESI+):Calculated for C20H37N4O7[M+H]+:445.2657;Found:445.2653。
the results of testing the surface topography of the micro-nano copper powder prepared in the above examples 1 to 8 are shown in fig. 1 to 8, respectively.
As can be seen from fig. 1 to 8, the micro-nano copper powder prepared in different embodiments is uniform in distribution and good in dispersibility, and the micro-nano copper powder prepared in different embodiments has different particle sizes. As can be seen from FIG. 1, the average particle size of the micro-nano copper powder prepared in example 1 is 500-600 nm. As can be seen from FIG. 2, the average particle size of the micro-nano copper powder prepared in example 2 is 600-700 nm. As can be seen from FIG. 3, the average particle size of the micro-nano copper powder prepared in example 3 is 500-600 nm. As can be seen from FIG. 4, the average particle size of the micro-nano copper powder prepared in example 4 is 600-800 nm. As can be seen from fig. 5, the average particle size of the micro-nano copper powder prepared in example 5 is 1 um. As can be seen from FIG. 6, the average particle size of the micro-nano copper powder prepared in example 6 is 1-1.2 um. As can be seen from FIG. 7, the average particle size of the micro-nano copper powder prepared in example 7 is 600-800 nm. As can be seen from FIG. 8, the average particle size of the micro-nano copper powder prepared in example 8 is 500-600 nm.
XRD (X-ray diffraction) patterns of the micro-nano copper powder prepared in the example 1 and the standard copper powder are shown in figure 9. Wherein the Synthesized Copper in fig. 9 is an XRD pattern of the micro-nano Copper powder prepared in example 1 of the present application, and PDF #04-0836Copper is a standard Copper powder XRD pattern. From fig. 9, it can be seen that the prepared micro-nano copper powder map is close to the standard copper powder map, which indicates that the copper powder is synthesized by the method of the present application.
The resistivity and the conductivity of the micro-nano copper powder prepared in example 1 are tested, and the results are shown in fig. 10-11.
The resistivity tests of fig. 10 and 11 were performed using an automated powder resistivity tester model ST2742B, manufactured by suzhou crystal lattice electronics limited, and show data on resistivity and conductivity of the samples to be tested at 2-30 MPa. The test method comprises the following steps: 2g of the sample was taken and placed in a sample cell and an automated powder resistivity tester was started to test the resistivity of the sample at different pressures. And (3) testing temperature: and (4) room temperature.
According to the results shown in fig. 10 and fig. 11, the micro-nano copper powder prepared by using the novel peptide-like compound as the dispersant has low resistivity and high conductivity, and the dispersant can play a good role in oxidation resistance and agglomeration prevention.
The above description is only for the purpose of illustrating the preferred embodiments of the present invention and is not to be construed as limiting the invention, and any modifications, equivalents, improvements and the like that fall within the spirit and principle of the present invention are intended to be included therein.
Claims (10)
1. The application of the peptide-like compound is characterized in that the peptide-like compound is applied to preparation of micro-nano metal powder as a dispersing agent, wherein the peptide-like compound is a beta-hydroxybutyryl-amino acid compound, and the structural formula of the beta-hydroxybutyryl-amino acid is as follows:(R)nis alpha-amino acid substituent or polypeptide chain formed by alpha-amino acid condensation polymerization.
2. A preparation method of micro-nano metal powder is characterized by comprising the following steps: adding the peptoid compound and the metal salt of claim 1 into a solvent, uniformly mixing, adding a reducing agent, stirring for reaction, filtering, and collecting precipitates to obtain the micro-nano metal powder.
3. The method for preparing micro-nano metal powder according to claim 2, wherein the metal salt is copper salt.
4. The method for preparing micro-nano metal powder according to claim 3, wherein the copper salt comprises at least one of copper sulfate, copper chloride and copper nitrate.
5. The method for preparing micro-nano metal powder according to claim 2, wherein the reducing agent comprises at least one of ascorbic acid, formic acid, oxalic acid, sodium borohydride and sodium hypophosphite.
6. The method for preparing micro-nano metal powder according to claim 2, wherein the solvent comprises at least one of water, DMF, DMSO, ethylene glycol, glycerol and acetone.
7. The preparation method of the micro-nano metal powder as claimed in claim 2, wherein the peptoid compound and the metal salt are added into a solvent, uniformly mixed, added with a reducing agent, adjusted to have a pH value of 7-10, stirred for reaction, filtered, and precipitated to obtain the micro-nano metal powder.
8. The method for preparing micro-nano metal powder according to claim 2, wherein in the step of stirring for reaction, the reaction time is 0.5-1 h.
9. The preparation method of the micro-nano metal powder as claimed in claim 2, wherein the mass-to-volume ratio of the peptoid compound, the metal salt, the reducing agent and the solvent is (0.5-5) g, (0.5-10) g, (1-5) g, (50-500) mL.
10. The micro-nano metal powder is characterized by being prepared by the preparation method according to any one of claims 2 to 9.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110549512.3A CN113262719A (en) | 2021-05-20 | 2021-05-20 | Application of peptide-like compound, micro-nano metal powder and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110549512.3A CN113262719A (en) | 2021-05-20 | 2021-05-20 | Application of peptide-like compound, micro-nano metal powder and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN113262719A true CN113262719A (en) | 2021-08-17 |
Family
ID=77231978
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110549512.3A Pending CN113262719A (en) | 2021-05-20 | 2021-05-20 | Application of peptide-like compound, micro-nano metal powder and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113262719A (en) |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011026572A1 (en) * | 2009-09-01 | 2011-03-10 | Eth Zurich | Dispersant stabilization of inorganic non-metallic particles |
US20110230427A1 (en) * | 2010-03-22 | 2011-09-22 | David Bruce Robinson | Materials and methods for stabilizing nanoparticles in salt solutions |
CN105268991A (en) * | 2015-11-09 | 2016-01-27 | 上海纳米技术及应用国家工程研究中心有限公司 | Method for preparing high-concentration nano silver monomer dispersion liquid |
BR102016004486A2 (en) * | 2016-02-29 | 2016-02-29 | CISTEINIL SYNTHETIC PEPTIDES AS REDUCING AND STABILIZING AGENTS IN THE GREEN SYNTHESIS OF A STAGE OF METALLIC NANOPARTICLES AND QUANTUM DOTS WITH MORPHOLOGY AND SIZE MODULATED BY THE PH | |
CN108017555A (en) * | 2017-11-28 | 2018-05-11 | 郑州海斯威生物技术有限公司 | A kind of beta-hydroxy butyryl-amino-acid compound and preparation method and application |
CN108394927A (en) * | 2018-04-13 | 2018-08-14 | 唐山学院 | A kind of preparation method of the nano cupric oxide of morphology controllable |
-
2021
- 2021-05-20 CN CN202110549512.3A patent/CN113262719A/en active Pending
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011026572A1 (en) * | 2009-09-01 | 2011-03-10 | Eth Zurich | Dispersant stabilization of inorganic non-metallic particles |
US20110230427A1 (en) * | 2010-03-22 | 2011-09-22 | David Bruce Robinson | Materials and methods for stabilizing nanoparticles in salt solutions |
CN105268991A (en) * | 2015-11-09 | 2016-01-27 | 上海纳米技术及应用国家工程研究中心有限公司 | Method for preparing high-concentration nano silver monomer dispersion liquid |
BR102016004486A2 (en) * | 2016-02-29 | 2016-02-29 | CISTEINIL SYNTHETIC PEPTIDES AS REDUCING AND STABILIZING AGENTS IN THE GREEN SYNTHESIS OF A STAGE OF METALLIC NANOPARTICLES AND QUANTUM DOTS WITH MORPHOLOGY AND SIZE MODULATED BY THE PH | |
CN108017555A (en) * | 2017-11-28 | 2018-05-11 | 郑州海斯威生物技术有限公司 | A kind of beta-hydroxy butyryl-amino-acid compound and preparation method and application |
CN108394927A (en) * | 2018-04-13 | 2018-08-14 | 唐山学院 | A kind of preparation method of the nano cupric oxide of morphology controllable |
Non-Patent Citations (2)
Title |
---|
王爱丽等: "不同有机官能团对室温下纳米银形貌控制合成的影响", 《贵金属》, vol. 27, no. 02, 30 June 2006 (2006-06-30) * |
王静等: "单分散的银纳米粒子的制备及表征", 《江苏科技大学学报(自然科学版)》, vol. 24, no. 04, 31 August 2010 (2010-08-31), pages 350 - 352 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Li et al. | Preparation of water-soluble magnetite nanocrystals from hydrated ferric salts in 2-pyrrolidone: mechanism leading to Fe3O4 | |
CN103157803A (en) | Method of preparing nano-alloy through solid phase chemical reaction | |
CN109485085B (en) | A kind of preparation method of hollow octahedra cuprous oxide | |
CN111871400B (en) | Preparation method and application of guanidine salt ionic liquid modified magnetic solid phase extraction adsorbent | |
CN104174864A (en) | Preparation method of nano or submicron silver particle powder | |
CN107602449B (en) | Preparation and application of zinc complex fluorescent probe with graphite-like structure | |
CN103303980B (en) | The method of sulfonated lignin template synthesis nano-sized iron oxide | |
WO2015025558A1 (en) | Method for collecting scandium | |
CN113814408B (en) | Preparation and component regulation and control method of CuPd alloy nanocrystalline | |
CN113262719A (en) | Application of peptide-like compound, micro-nano metal powder and preparation method thereof | |
CN104650358B (en) | Porphyrin-based heteronuclear double-metal polymer, and preparation method and applications thereof | |
CN114958752A (en) | Multifunctional magnetic nano composite material and preparation method and application thereof | |
CN108587569B (en) | Oil-soluble ferroferric oxide/modified graphene oxide composite material and preparation method and application thereof | |
CN113275584B (en) | Micro-nano silver powder and preparation method and application thereof | |
CN108976148A (en) | A kind of preparation method of 1,2- Propane Diamine 5- bromosalicylaldehyde Bis-Schiff Bases corrosion inhibiter | |
CN1810293A (en) | Magnetic resonance imaging contrast medium based on metal fullerene and its prepn process | |
CN106588681B (en) | A kind of method that L alanine is prepared using hydroxyproline waste water as raw material | |
CN110474059A (en) | A kind of method, catalyst and its application of solid phase magnanimity synthesis non noble metal oxygen reduction catalyst | |
CN114988478A (en) | Method for preparing battery-grade manganese sulfate by synergistic elution crystallization of chelating agent | |
CN114150339B (en) | Catalyst and preparation method and application thereof | |
Voronkova et al. | Complexation and flotation of nonferrous metal ions from alkaline solutions with N-acyl-N′-(p-toluenesulfonyl) hydrazines | |
CN110681875B (en) | Isosteviol metal gel and preparation method and application thereof | |
CN112759553B (en) | Synthesis and application of water-soluble pyridazine derivative | |
US20140017164A1 (en) | Process for preparing magnetite (fe3o4) and derivatives thereof | |
CN112604668A (en) | Dy-doped Fe3O4Adsorption material of grafted polyamide-amine and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20210817 |
|
RJ01 | Rejection of invention patent application after publication |